373 related articles for article (PubMed ID: 25836578)
41. The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells.
Zhang S; Dutton JR; Su L; Zhang J; Ye L
Biomaterials; 2014 Apr; 35(12):3786-93. PubMed ID: 24485793
[TBL] [Abstract][Full Text] [Related]
42. Single-cell protein expression of hiPSC-derived cardiomyocytes using Single-Cell Westerns.
Jabart E; Molho J; Sin K; Stansfield B; Kazmouz SG; Ventro D; Gardner K; Wu JC; Churko JM
J Mol Cell Cardiol; 2020 Dec; 149():115-122. PubMed ID: 33010256
[TBL] [Abstract][Full Text] [Related]
43. Establishment of an automated patch-clamp platform for electrophysiological and pharmacological evaluation of hiPSC-CMs.
Li W; Luo X; Ulbricht Y; Wagner M; Piorkowski C; El-Armouche A; Guan K
Stem Cell Res; 2019 Dec; 41():101662. PubMed ID: 31809994
[TBL] [Abstract][Full Text] [Related]
44. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
Iglesias-García O; Pelacho B; Prósper F
J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
[TBL] [Abstract][Full Text] [Related]
45. Oxygen consumption of human heart cells in monolayer culture.
Sekine K; Kagawa Y; Maeyama E; Ota H; Haraguchi Y; Matsuura K; Shimizu T
Biochem Biophys Res Commun; 2014 Sep; 452(3):834-9. PubMed ID: 25218502
[TBL] [Abstract][Full Text] [Related]
46. Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch.
Miyagawa S; Kawamura T; Ito E; Takeda M; Iseoka H; Yokoyama J; Harada A; Mochizuki-Oda N; Imanishi-Ochi Y; Li J; Sasai M; Kitaoka F; Nomura M; Amano N; Takahashi T; Dohi H; Morii E; Sawa Y
Stem Cell Res Ther; 2024 Mar; 15(1):73. PubMed ID: 38475911
[TBL] [Abstract][Full Text] [Related]
47. Application of Human Induced Pluripotent Stem Cell Technology for Cardiovascular Regenerative Pharmacology.
Majid QA; Orsolits B; Pohjolainen L; Kovács Z; Földes G; Talman V
Methods Mol Biol; 2022; 2454():163-196. PubMed ID: 33755910
[TBL] [Abstract][Full Text] [Related]
48. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.
Li Z; Hu S; Ghosh Z; Han Z; Wu JC
Stem Cells Dev; 2011 Oct; 20(10):1701-10. PubMed ID: 21235328
[TBL] [Abstract][Full Text] [Related]
49. Calcium and voltage mapping in hiPSC-CM monolayers.
Herron TJ
Cell Calcium; 2016 Mar; 59(2-3):84-90. PubMed ID: 26922095
[TBL] [Abstract][Full Text] [Related]
50. Differentiation and Contractile Analysis of GFP-Sarcomere Reporter hiPSC-Cardiomyocytes.
Sharma A; Toepfer CN; Schmid M; Garfinkel AC; Seidman CE
Curr Protoc Hum Genet; 2018 Jan; 96():21.12.1-21.12.12. PubMed ID: 29364522
[TBL] [Abstract][Full Text] [Related]
51. CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice.
Fan C; Tang Y; Zhao M; Lou X; Pretorius D; Menasche P; Zhu W; Zhang J
J Mol Cell Cardiol; 2020 Apr; 141():1-10. PubMed ID: 32169551
[TBL] [Abstract][Full Text] [Related]
52. Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells.
Wang L; Su W; Du W; Xu Y; Wang L; Kong D; Han Z; Zheng G; Li Z
Stem Cell Rev Rep; 2015 Apr; 11(2):219-27. PubMed ID: 25618294
[TBL] [Abstract][Full Text] [Related]
53. Electrophysiological evaluation of human induced pluripotent stem cell-derived cardiomyocytes obtained by different methods.
Prajapati C; Ojala M; Lappi H; Aalto-Setälä K; Pekkanen-Mattila M
Stem Cell Res; 2021 Mar; 51():102176. PubMed ID: 33485184
[TBL] [Abstract][Full Text] [Related]
54. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
[TBL] [Abstract][Full Text] [Related]
55. Non-viral vector based gene transfection with human induced pluripotent stem cells derived cardiomyocytes.
Tan S; Tao Z; Loo S; Su L; Chen X; Ye L
Sci Rep; 2019 Oct; 9(1):14404. PubMed ID: 31591436
[TBL] [Abstract][Full Text] [Related]
56. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
57. Cardiac differentiation potential of human induced pluripotent stem cells in a 3D self-assembling peptide scaffold.
Puig-Sanvicens VA; Semino CE; Zur Nieden NI
Differentiation; 2015; 90(4-5):101-10. PubMed ID: 26707885
[TBL] [Abstract][Full Text] [Related]
58. Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells.
Xi J; Khalil M; Shishechian N; Hannes T; Pfannkuche K; Liang H; Fatima A; Haustein M; Suhr F; Bloch W; Reppel M; Sarić T; Wernig M; Jänisch R; Brockmeier K; Hescheler J; Pillekamp F
FASEB J; 2010 Aug; 24(8):2739-51. PubMed ID: 20371616
[TBL] [Abstract][Full Text] [Related]
59. The Effect of Uncoated SPIONs on hiPSC-Differentiated Endothelial Cells.
Salingova B; Simara P; Matula P; Zajickova L; Synek P; Jasek O; Veverkova L; Sedlackova M; Nichtova Z; Koutna I
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331030
[TBL] [Abstract][Full Text] [Related]
60. Large-Scale Differentiation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Stirring-Type Suspension Culture.
Sougawa N; Miyagawa S; Sawa Y
Methods Mol Biol; 2021; 2320():23-27. PubMed ID: 34302644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
